# Early Clinical Outcomes of Full-Arch Rehabilitations with Immediately Loaded Implants with Buccal Dehiscence Treated with Horizontal Augmentation: A 1-Year Retrospective Case Series

**Authors:** Alfonso Acerra, Mario Caggiano, Angelo Aliberti, Michele Langone, Francesco Giordano

PMC · DOI: 10.3390/dj14020121 · Dentistry Journal · 2026-02-19

## TL;DR

This study examines the early success of dental implants placed in areas with bone loss and treated with bone augmentation, showing promising results with low failure rates.

## Contribution

The study provides descriptive clinical outcomes of immediately loaded implants in augmented sites with buccal dehiscence.

## Key findings

- Two implant failures occurred in augmented sites (1.35%) with no failures in non-augmented sites.
- Only two biological complications were observed, both involving augmented implants.
- The estimated risk ratio for implant failure with augmentation was 3.56 but not statistically significant.

## Abstract

Background: Buccal bone dehiscence is a frequent finding during implant placement and often requires horizontal bone augmentation. When combined with immediate loading protocols, concerns remain regarding early implant stability and failure risk. This retrospective case series aimed to describe the early clinical outcomes of immediately loaded implants placed in sites with buccal dehiscence treated by horizontal bone augmentation and restored with full-arch screw-retained prostheses. Methods: Fifty-nine consecutive edentulous patients were rehabilitated with immediately loaded cross-arch implant-supported prostheses. A total of 253 implants were placed, including 148 implants presenting buccal dehiscence and treated with horizontal bone augmentation using particulate grafting materials with or without autogenous bone and a resorbable collagen membrane. Clinical outcomes were assessed over a 1-year follow-up period. Implant survival and biological complications were recorded. Descriptive statistics were applied. An exploratory event-based comparison between augmented and non-augmented implants was performed using Fisher’s exact test, and risk ratios (RRs) with 95% confidence intervals (CIs) were calculated. Results: At 1 year, no patients were lost to follow-up. Two implant failures occurred, both in augmented sites (2/148; 1.35%), while no failures were observed among non-augmented implants (0/105). The exploratory comparison did not show a statistically significant difference in failure rates between groups (p = 0.51). The estimated RR for implant failure associated with horizontal augmentation was 3.56 (95% CI: 0.17–73.34). Two biological complications (one peri-implantitis and one peri-implant mucositis) were recorded, both involving augmented implants. Conclusions: Within the limitations of this retrospective case series, immediately loaded implants placed in sites with buccal dehiscence and treated with horizontal bone augmentation demonstrated high early survival rates and a low incidence of biological complications. These findings are descriptive and exploratory and should be interpreted as hypothesis-generating. Further prospective controlled studies with longer follow-up are needed to confirm these observations.

## Full-text entities

- **Diseases:** bleeding (MESH:D006470), injury to (MESH:D014947), gingival recession (MESH:D005889), dehiscence (MESH:D013529), fracture (MESH:D050723), recession (MESH:C565432), mucositis (MESH:D052016), peri-implantitis (MESH:D057873), resorption (MESH:D014091), deformations (MESH:D009140), allergic (MESH:D004342), fistulas (MESH:D005402), edentulism (MESH:D007575), Buccal Dehiscence (MESH:D000080902), infection (MESH:D007239), bone (MESH:D001847), numbness (MESH:D006987)
- **Chemicals:** water (MESH:D014867), chlorhexidine gluconate (MESH:C010882), chlorhexidine (MESH:D002710), amoxicillin (MESH:D000658), Ibuprofen (MESH:D007052), clarithromycin (MESH:D017291), epinephrine (MESH:D004837), clavulanic acid (MESH:D019818), mepivacaine (MESH:D008619), Vicryl 4 (-), Penicillin (MESH:D010406), titanium (MESH:D014025)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939081/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939081/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939081/full.md

---
Source: https://tomesphere.com/paper/PMC12939081